Term
|
Definition
catalyzes the phosphorylation of Glucose to glucose 6-P 1 ATP used |
|
|
Term
hexose phosphate isomerase |
|
Definition
catalyzes the isomerization of Glucose 6-P to fructose 6-P |
|
|
Term
phosphofructokinase-1 (PFK-1) |
|
Definition
catalyzes the phosphorylation of Fructose 6-P to fructose 1,6-BP 1 ATP used |
|
|
Term
|
Definition
catalyzes the C3 hydrolysis of fructose 6-P to glyceraldehyde 3-P and dihydroxyacetone phosphate |
|
|
Term
|
Definition
catalyzes the isomerization of dihydroxyacetonephosphate to glyceraldehyde 3-P |
|
|
Term
glyceraldehyde 3-phosphate dehydrogenase |
|
Definition
catalyzes the phosphorylation of glyceraldehyde 3-P to glyceraldehyde 1,3 BP |
|
|
Term
glyceraldehyde phosphate kinase |
|
Definition
catalyzes the dephosphorylation of glyceraldehyde 1,3 BP to glyceraldehyde 3P
(1 ATP generated) x 2 molecules |
|
|
Term
glyceraldehyde phosphate mutase |
|
Definition
catalyzes the isomerization of glyceraldeyde 3P to glyceraldehyde 2P |
|
|
Term
|
Definition
catalyzes the dehydration of glyceraldehyde 2P to phosphoenolpyruvate |
|
|
Term
|
Definition
catalyzes the dephosphorylation of phosphoenolpyruvate to pyruvate
(1 ATP formed) x 2 |
|
|
Term
|
Definition
2 ATP used 4 ATP made 2 NADH made 2 Pyruvate made |
|
|
Term
|
Definition
reaction 3 synthesis of fructose 1,6-BP |
|
|
Term
|
Definition
step 1 Hexokinase activity step 3 PFK-1 activity step 10 pyruvate Kinase activity |
|
|
Term
control point 1 inhibitors |
|
Definition
Glucose 6-P (feedback inhibition in pancreas, but in liver where hexokinase is replaced by glucokinase no inhibition) Hexokinase has high Km for glucose glucokinase has low Km for glucose |
|
|
Term
control point 2 inhibitor |
|
Definition
ATP (high [ATP] phosphorylate/inactivates PFK-2 blocking the synthesis of Fructose 2,6BPG) Citrate (feedback inhibition) |
|
|
Term
control point 2 activator |
|
Definition
cAMP (activates protein Kinase A which dephosphorylates/activates PFK-2) Fructose 2,6 BP (high concentration activates PFK1) |
|
|
Term
regulation of PFK-2 in heart and liver |
|
Definition
heart: phosphorylation activates PFK-2 leading to glycolysis
liver: dephosphorylation activates PFK-2 leading to glycolysis |
|
|
Term
Control point 3- inhibitors |
|
Definition
ATP (phoaphorylation inactivates pyruvate kinase) alanine (product of pyruvate metabolism, feedback inhibition) |
|
|
Term
Control Point 3- activator |
|
Definition
|
|
Term
insulin's effect on glucose in liver |
|
Definition
insulin activates glycolysis
decreases cAMP==> deactivate kinase A ==>dephosphorylates/activate pfk-2 ==> synthesis Fructose 2,6 BP ==> increased concentration activate pfk-1 ==> glycolysis |
|
|
Term
epinephrines's effect on glucose in heart |
|
Definition
Epi activates glycolysis
upregulates cAMP ==> activate Kinase A ==> phosphorylates pfk2 ==> increases fructose 2,6 BP => activates pfk1 |
|
|
Term
glucagon's effect on glucose in liver |
|
Definition
deactivates glucolysys
similare process as insulin only the phosphorylate pfk-2 in liver is inactive |
|
|
Term
glycolysis inhibitors/ downregulators |
|
Definition
iodoacetate arsenate ions 2,3 BPG-shunt |
|
|
Term
|
Definition
competetively inhibits the step 6 enzyme glyceraldehyde 3 phosphate dehydrogenase by binding to the thiol group of the enzyme preveenting the substrate from binding |
|
|
Term
|
Definition
inhibits the step 6 enzyme glyceraldehyde 3P DH by competing for the binding site of the inorganic phosphate |
|
|
Term
|
Definition
A step 7 side reaction that can take 1,3 BPG to 2,3 BPG bypassing the ATP producing dephosphorylation reaction catalyzed by phosphoglycerate kinase |
|
|